<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial

dc.contributor.authorLorusso, Domenica
dc.contributor.authorGladieff, Laurence
dc.contributor.authorO'Malley, David M.
dc.contributor.authorKim, Jae Weon
dc.contributor.authorGarbaos, Gabriel
dc.contributor.authorFagotti, Anna
dc.contributor.authorGilbert, Lucy
dc.contributor.authorMileshkin, Linda
dc.contributor.authorQuesada, Stanislas
dc.contributor.authorHopp, Elizabeth
dc.contributor.authorLee, Yong Jae
dc.contributor.authorOaknin, Ana
dc.contributor.authorScaranti, Mariana
dc.contributor.authorKim, Byoung-Gie
dc.contributor.authorClamp, Andrew
dc.contributor.authorPrillaman, Christina
dc.contributor.authorDiakos, Connie
dc.contributor.authorBagaméri, Andrea
dc.contributor.authorLeiser, Aliza L.
dc.contributor.authorSalutari, Vanda
dc.contributor.authorMonk, Bradley J.
dc.contributor.authorFollana, Philippe
dc.contributor.authorMcClung, Emily
dc.contributor.authorCarbone, Vittoria
dc.contributor.authorSlomovitz, Brian M.
dc.contributor.authorGiudice, Elena
dc.contributor.authorCannizzaro, Maria Chiara
dc.contributor.authorGavoille, Laurene
dc.contributor.authorDevaux, Alix
dc.contributor.authorScollo, Paolo
dc.contributor.authorScandurra, Giuseppa
dc.contributor.authorCassani, Chiara
dc.contributor.authorArtioli, Grazia
dc.contributor.authorVan Gorp, Toon
dc.contributor.authorSantaballa, Ana
dc.contributor.authorDreiling, Lyndah K.
dc.contributor.authorKesner-Hays, Amanda
dc.contributor.authorTudor, Iulia Cristina
dc.contributor.authorJubb, Adrian M.
dc.contributor.authorColombo, Nicoletta
dc.contributor.authorOlawaiye, Alexander B.
dc.contributor.authorPóka, Róbert
dc.date.accessioned2026-04-20T07:50:54Z
dc.date.available2026-04-20T07:50:54Z
dc.date.issued2026
dc.date.oa2026-06-17
dc.date.pasync2026-06-16T23:11:34Z
dc.date.updated2026-04-20T07:50:54Z
dc.description.correctorbkata
dc.identifier.citationLancet. -407 : 10538 (2026), p. 1513-1524. -Lancet. - 0140-6736
dc.identifier.doihttp://dx.doi.org/10.1016/S0140-6736(26)00462-9
dc.identifier.issn0140-6736
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM136836
dc.identifier.scopus105035713563
dc.identifier.urihttps://hdl.handle.net/2437/406348
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0140673626004629
dc.identifier.wos001751766500001
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleOverall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban

Fájlok

Eredeti köteg (ORIGINAL bundle)

Megjelenítve 1 - 2 (Összesen 2)
Betöltés ...
Bélyegkép
Név:
FILE_UP_1_Lorusso - Lancet - 2026.pdf
Méret:
782,2 KB
Formátum:
Adobe Portable Document Format
Leírás:
Kiadói változat
Betöltés ...
Bélyegkép
Név:
FILE_UP_2_Lorusso - Lancet - függelék - 2026.pdf
Méret:
4,98 MB
Formátum:
Adobe Portable Document Format